Search results for "Infarctus"

showing 10 items of 12 documents

Silent and symptomatic atrial fibrillation,during the acute phase of myocardial infarction : determinants and role of arginine methylated and oxidati…

2015

Atrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI) with a poorer prognosis. Silent atrial fibrillation has been suggested to be frequent after AMI. However, most part of the studies has targeted only paroxysmal or persistent AF. Thus, Reduced Nitric Oxide availability and endothelial dysfunction has been recently recognized as a possible contributor to altered prognosis in AF. Asymmetric dimethylarginine (ADMA) can inhibit nitric oxide synthase and leads to endothelial dysfunction, inflammation and oxidative stress in multiple cardiovascular diseases. However, any study has addressed the relationship between ADMA levels and the occurrence of AF in AMI.W…

Fibrillation atriale silencieuse[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyAsymmetric diméthylarginine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyAsymétrique diméthylarginineSilent Atrial fibrillationPronosticInfarctus du myocarde en phase aiguëAcute myocardial infarctionMonitoring ECG en continuPrognosisContinuous ECG monitoring[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Soins ambulatoires et facteurs associés à la réhospitalisation précoce des sujets âgés (65+) après un infarctus du myocarde : étude observationnelle …

2017

Etat de la question Les rehospitalisations precoces (RHP), dans les 30 jours suivant la sortie d’hospitalisation, sont frequentes chez les sujets âges, notamment apres un infarctus du myocarde (IDM). Elles augmentent la morbi-mortalite et les depenses de sante. Il a ete demontre qu’une meilleure organisation de la sortie d’hospitalisation reduit significativement le risque de RHP. Neanmoins, il n’existe aucune recommandation sur le suivi ambulatoire en sortie d’hospitalisation. L’objectif de l’etude etait d’analyser les soins ambulatoires post-hospitaliers et les facteurs associes a la RHP des sujets âges apres un IDM. Materiel et methodes Etude observationnelle retrospective a partir des d…

[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemEpidemiologySoins ambulatoiresRéhospitalisationPublic Health Environmental and Occupational HealthInfarctus du myocarde[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemBase de données administrativesSujets âgésRevue d'Épidémiologie et de Santé Publique
researchProduct

Iron metabolism markers and l-arginine derivatives in coronary artery disease : highlighting, assessment and role of oxidative stress in acute myocar…

2015

Myocardial infarction (MI) is mostly caused by complications of atherosclerosis, whose the development would be initiated by a dysfunction of the vascular endothelium, characterized by an inflammatory condition and oxidative stress.In this pathogenesis, iron interacts at different levels and also has a major role in the development of endothelial dysfunction. Hepcidin and erythroferrone (discovered earlier as the myonectin/CTRP 15) participate in a major way in regulating certain stages of iron metabolism.Asymmetric dimethylarginine (ADMA), a marker of endothelial dysfunction is associated with most cardiovascular risk factors. Symmetrical dimethyl-arginine (SDMA), its stereoisomer, has an …

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyIronHepcidineGlycémieHepcidinDiméthylAcute myocardial infarctionPhase aiguë infarctus du myocardeFerAsymmetric dimethylarginine (ADMA)Glucose[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyArginine asymétrique (ADMA)Diméthyl arginine symétrique (SDMA)[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologySymmetric dimethylarginine (SDMA)Erythroferrone
researchProduct

Incidences de l’ischémie cérébrale sur la fonction et la sensibilité cardiaques à l’ischémie

2019

For years, the relationship between cardiac and neurological ischemic events has been limited to overlapping pathophysiological mechanisms and common risk factors. However, acute stroke may induce dramatic changes in cardiovascular function.The aim of this study was to evaluate how prior cerebrovascular lesions affect myocardial function and signaling in vivo and ex vivo, and how they influence cardiac vulnerability to ischemia-reperfusion injury and the expression of cardiac genes and proteins involved in cardioprotective pathways.Thus, in our work, we studied cardiac function in a rat stroke model induced by cerebral embolization.The main results show that experimental stroke 1/ impaired …

StrokeIschémieMyocardial infarctionAvcStress oxydant[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyIschemiaOxidative stressInfarctusHeart[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyCoeur
researchProduct

Epidemiological approach of type 2 myocardial infarction : Etiologies, characteristics, treatment and prognosis.

2020

Introduction: Type 2 Myocardial infarction (MI)has been recently defined as an imbalance between oxygen supply and demand, in the absence of atherothromthrombosis. This work aimed to describe the main etiolgies as well as epidemiological, clinical and prognostic characteristics.Method: Data from patients with type 2 MI were collected from the RICO cohort (Observatoire des Infarctus de Cote d'Or). In a complementary work, we analyzed the retrospective data of the emergency department of Dijon University Hospital.Results: Among 4,436 consecutive patients hospitalized for MI in Dijon emergency department over 3 years, 947 (21%) had type 2 MI (median age: 81 years). In the RICO cohort, 4,572 co…

Infactus du myocardeÉpidémiologieMyocardial infarctionEtiologies[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyÉtiologiesEpidemiologyTyoe 2 myocardial infarctionInfarctus de type 2PronosticPrognosis[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.

2016

IF 2.271; International audience; Background. - Clinical studies have shown a beneficial effect of cardiac rehabilitation (CR) on mortality.Objective. - To study the effect of CR prescription at discharge on 5-year mortality in patients with acute myocardial infarction (AMI).Methods. - Participants, from the 2005 French FAST-MI hospital registry, were 2894 survivors at discharge, divided according to AMI type: ST-segment elevation myocardial infarction (STEMI; n=1523) and non-STEMI (NSTEMI; n=1371). The effect of CR prescription on mortality was analysed using a Cox proportional hazards model.Results. - At discharge, 22.1% of patients had a CR prescription. Patients referred to CR were youn…

MaleMESH: Chi-Square Distributionmedicine.medical_treatmentMESH : Acute Coronary SyndromeMyocardial InfarctionMESH : AgedMESH : Prospective StudiesCardiac rehabilitationMESH: Risk Assessment0302 clinical medicineMyocardial infarctionProspective StudiesReferral and ConsultationMESH: Treatment OutcomeRehabilitationMESH: Middle AgedGeneral MedicineMESH: Follow-Up Studies3. Good healthMESH: Myocardial InfarctionMESH : Patient DischargeCardiology and Cardiovascular Medicinemedicine.medical_specialtyAcute myocardial infarctionMortalitéRisk Assessment03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHumansMESH : Middle AgedAcute Coronary SyndromeMESH: Kaplan-Meier EstimateAgedChi-Square DistributionMESH: HumansMESH : Chi-Square DistributionProportional hazards modelMESH: Patient DischargeMESH : HumansPatient survivalMESH : Follow-Up Studiesmedicine.diseaseMESH : Proportional Hazards ModelsMESH: Acute Coronary SyndromeST-segment elevation myocardial infarctionMESH: FemaleTime FactorsMESH: RegistriesKaplan-Meier Estimate030204 cardiovascular system & hematologyMESH : Referral and ConsultationMESH: Proportional Hazards ModelsOlder patientsRisk FactorsMESH: Risk FactorsMESH : Female030212 general & internal medicineRegistriesMESH : Risk AssessmentMESH: AgedEjection fractionNon–ST-segment elevation myocardial infarctionMiddle Aged[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMESH : Risk FactorsPatient DischargeTreatment OutcomeFemaleFranceMESH : Time FactorsMESH : MaleMESH : Treatment OutcomeMESH: Multivariate AnalysisMESH : Kaplan-Meier EstimateMESH: Referral and ConsultationInternal medicineInfarctus du myocarde sans sus-décalage du segment STmedicineIn patientcardiovascular diseasesMedical prescriptionMortalityRéadaptation cardiaqueMESH : FranceProportional Hazards Modelsbusiness.industryInfarctus du myocarde avec sus-décalage du segment STMESH: Time FactorsMESH : Multivariate AnalysisMESH: MaleMESH: Prospective StudiesSurgeryMESH: FranceInfarctus du myocarde aiguMultivariate AnalysisMESH : Myocardial InfarctionbusinessMESH : RegistriesFollow-Up Studies
researchProduct

Infarctus cérébral et plasticité : focus sur le BDNF

2011

Functional recovery after ischemic stroke largely involves brain plasticity and more accurately its ability to reorganize the neuronal networks spared by the infarct. Studies conducted on animals using different ischemic stroke models have demonstrated that plastic changes are induced by BDNF (Brain-Derived Neurotrophic Factor). Hence, increasing levels of BDNF in the brain is considered a promising therapeutic strategy to reduce post-stroke impairments. In this context, our work had 2 aims: 1) In a rat model, to identify cells involved in the over-production of BDNF and to evaluate the pertinence of the measurement of circulating BDNF levels to estimate brain BDNF levels; 2) In ischemic st…

SérumSerum[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyRécupération motricePlasticityMotor recoveryAccident vasculaire cérébralStrokePlasmaBDNFPlasticitéCerebral infarctFluoxetin[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyRatInfarctus cérébralFluoxétine
researchProduct

New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction

2015

International audience; Atrial fibrillation (AF) is the most frequent heart rhythm disorder in the general population and contributes not only to a major deterioration in quality of life but also to an increase in cardiovascular morbimortality. The onset of AF in the acute phase of myocardial infarction (MI) is a major event that can jeopardize the prognosis of patients in the short-, medium- and long-term, and is a powerful predictor of a poor prognosis after MI. The suspected mechanism underlying the excess mortality is the drop in coronary flow linked to the acceleration and arrhythmic nature of the left ventricular contractions, which reduce the left ventricular ejection fraction. The p…

medicine.medical_specialtyAsymmetric dimethylarginineSurveillance ECG en continueAsymétrique diméthylargininePopulationMyocardial InfarctionInfarctus du myocardeAcute myocardial infarctionSudden deathContinuous ECG monitoringVentricular Function Left[SHS]Humanities and Social SciencesHeart RateRisk FactorsInternal medicineCoronary CirculationHeart rateAtrial FibrillationmedicinePronosticHumansMyocardial infarctionHospital MortalityeducationHeart FailureFibrillation atriale silencieuseeducation.field_of_studyEjection fractionbusiness.industryAtrial fibrillationStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisMyocardial ContractionOxidative StressSilent atrial fibrillationHeart failureAsymptomatic DiseasesCardiologyEndothelium Vascular[SHS] Humanities and Social SciencesbusinessCardiology and Cardiovascular Medicine
researchProduct

Study of leurocyte telomere lenght and transcription in patients in the acute phase of myocardial infarction

2011

Atherosclerosis with cardiovascular complications remains today one of the leading causes of death in developed countries. In this context, development of new biomarkers of atherosclerosis has an important place. Objectives of these biomarkers are: • to identify populations most at risk of developing cardiovascular complications, • to stratify patient groups to optimize their clinical management and therapeutic, • to reveal new therapeutic targets in the treatment of the disease. In this context, we identified three biomarkers of interest, leukocyte telomere length (LTL) and level of expression of leukocyte genes c-Fos (involved in inflammatory processes and oxidative) and OGG1 (necessary r…

Bio-marqueursLongueur des télomères leucocytairesInflammationPathologies athéromateuses[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyC-FosTabacStress oxydatifNo english keywordsInfarctus du myocardeOGG1Statines
researchProduct

Travail posté et maladies cérébro- et cardiovasculaires : revue critique et synthèse des preuves épidémiologiques

2013

National audience; Une revue critique de la littérature a été menée sur le lien entre travail posté (TP) et survenue de maladies cérébro- et cardiovasculaires (MCCV). Dans plusieurs études de bonne qualité, le TP est associé à une augmentation modeste mais significative du risque de maladies cardiaques ischémiques fatales et non fatales. Les conclusions sont moins claires pour le lien avec la mortalité cardiovasculaire ischémique et les pathologies cérébrovasculaires. Sur le plan de la causalité, des biais de sélection difficiles à prendre en compte sur le plan méthodologique ne peuvent être écartés pour expliquer ces associations observées. Lien causal ou marqueur socio-économique ? Cette …

EPIDEMIOLOGIECHRONOBIOLOGIE[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologySYSTEME NERVEUX CENTRALFACTEUR DE RISQUETRAVAIL DE NUITHORAIRE DE TRAVAILINFARCTUSCOEURCORONAROPATHIE[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemTRAVAIL POSTECERVEAUROTATION DES POSTESHORAIRE ATYPIQUE[SDV.NEU.NB] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyBIAIS[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemSYSTEME NERVEUX[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemDOSE-EFFETAPPAREIL CARDIOVASCULAIREMORTALITEACCIDENT VASCULAIRE CEREBRAL[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieORGANISATION DU TRAVAIL
researchProduct